Related Experiment Video
Updated: May 9, 2026
Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
Published on: June 28, 2013
Generation of human cardiomyocytes: a differentiation protocol from feeder-free human induced pluripotent stem cells
Elisa Di Pasquale1, Belle Song, Gianluigi Condorelli
1Humanitas Clinical and Research Center, Italy. elisadipa@gmail.com
Abstract:
In order to investigate the events driving heart development and to determine the molecular mechanisms leading to myocardial diseases in humans, it is essential first to generate functional human cardiomyocytes (CMs). The use of these cells in drug discovery and toxicology studies would also be highly beneficial, allowing new pharmacological molecules for the treatment of cardiac disorders to be validated pre-clinically on cells of human origin. Of the possible sources of CMs, induced pluripotent stem (iPS) cells are among the most promising, as they can be derived directly from readily accessible patient tissue and possess an intrinsic capacity to give rise to all cell types of the body (1). Several methods have been proposed for differentiating iPS cells into CMs, ranging from the classical embryoid bodies (EBs) aggregation approach to chemically defined protocols (2,3). In this article we propose an EBs-based protocol and show how this method can be employed to efficiently generate functional CM-like cells from feeder-free iPS cells.
Insights
Generating functional human cardiomyocytes (CMs) is crucial for studying heart development and diseases. This study presents an efficient embryoid body (EB) protocol to create CMs from induced pluripotent stem (iPS) cells.
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Functional human cardiomyocytes (CMs) are essential for investigating heart development and myocardial diseases.
- Induced pluripotent stem (iPS) cells offer a promising source for generating CMs due to their accessibility and differentiation potential.
- Current differentiation methods vary, including embryoid body (EB) aggregation and chemically defined protocols.
Purpose of the Study:
- To investigate events driving heart development.
- To elucidate molecular mechanisms of human myocardial diseases.
- To establish an efficient method for generating functional human CMs from iPS cells for research and drug discovery.
Main Methods:
- Development of an embryoid body (EB)-based protocol for cardiomyocyte differentiation.
- Utilization of feeder-free induced pluripotent stem (iPS) cells.
- Validation of the generated cells as functional CM-like cells.
Main Results:
- An efficient EB-based protocol was successfully established.
- Feeder-free iPS cells were differentiated into functional CM-like cells.
- The protocol demonstrates a viable method for generating human cardiomyocytes.
Conclusions:
- The proposed EB-based protocol efficiently generates functional CM-like cells from feeder-free iPS cells.
- This method supports pre-clinical validation of pharmacological molecules for cardiac disorders.
- The generated CMs are valuable tools for studying heart development and disease mechanisms.
More Related Videos
05:38Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
Published on: February 12, 2021
11:53Derivation of Highly Purified Cardiomyocytes from Human Induced Pluripotent Stem Cells Using Small Molecule-modulated Differentiation and Subsequent Glucose Starvation
Published on: March 18, 2015
